Antibody Response to SARS-CoV-2 After Natural Infection and Vaccination

IE users – if you are experiencing issues trying to register for this webinar, please use Chrome, Safari or Firefox.

Tuesday, March 9, 2021
12:00PM ET / 9:00 AM PT

Program Objectives
We invite you to join us on Tuesday, March 9, for a discussion on the following topics:
1. Review SARS-CoV-2 infection cycle and utility of molecular, antigen, and serology testing
2. Understand differences in natural and vaccine-induced immune response and how these influence serology testing.
3. Learn how Quest’s serology portfolio can be applied in different applications and populations.
4. Live Q&A session
Presented by:
Jay G. Wohlgemuth, MD
Chief Medical Officer
Senior Vice President, Research & Development and Medical
Quest Diagnostics, San Juan Capistrano, California
Hema Kapoor, MD SM, D(ABMM)
Senior Medial Director
Infectious Diseases & Immunology and Global Diagnostics Network
Quest Diagnostics
Moderated by:
William A. Meyer III, PhD, D(ABMM), MLS (ASCP)
Director, Medical Science Liaison, Infectious Diseases and Immunology and Technical Director, East Region
Quest Diagnostics